Medrio
<UNKNOWN>, US · Delaware corporation · 4 known investors
Medrio is an electronic data capture (EDC) platform designed for clinical trial teams at life sciences sponsors and contract research organizations. The platform offers no-code configuration, real-time data management, and expert clinical support to streamline trial execution.
Founders & leadership
MN
Michael NovotnyExecutive Officer, Director
RS
Richard SchellerDirector
DE
Doug EngferDirector
DL
Dave LipscombDirector
RD
Ryan DrantDirector
BS
Bradley SloanDirector
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$25MraisedMay 2017 · 2 investors · OtherRule 506(b)
▶$25MraisedMay 2017 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ryan DrantDirector
- Michael NovotnyExecutive Officer, Director
- Richard SchellerDirector
- Doug EngferDirector
- Dave LipscombDirector
- Bradley SloanDirector
- Offering amount
- $30M
- Amount sold
- $25M
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- eClinical specialist Medrio receives $30M equity investment from Questa Capital | Fierce Biotechfiercebiotech.com · 2017
- Medrio Raises $30M in First Equity Funding - FinSMEsfinsmes.com · 2017
- Medrio, Inc. Announces $30 Million Equity Investment from Questa Capitalprnewswire.com · 2017